A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Abroad (travel likely)Recruiting
Conditions
Pulmonary Hypertension · Heart Failure With Reduced Ejection Fraction · Hypertension · Vascular Diseases · Cardiovascular Diseases · Heart Failure · Heart Failure With Preserved Ejection Fraction · Heart Failure With Mid Range Ejection Fraction
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cardiovascular Institute of the South, Houma, Louisiana, United States
Oklahoma Heart Institute, Tulsa, Oklahoma, United States
University of Pittsburgh Medical Center, Mechanicsburg, Pennsylvania, United States
Study leads
Gregg W. Stone
Principal Investigator
Icahn School of Medicine at Mount Sinai